Safety is the first question almost everyone asks, and it deserves a straight answer rather than reassurance.
What ketamine actually is
Ketamine is a dissociative anesthetic and an NMDA receptor antagonist. It has been in medical use since the 1960s, primarily as an anesthetic, and it sits on the World Health Organization's list of essential medicines. In the United States it is a Schedule III controlled substance, which places it in the same regulatory tier as medications with recognized medical use and moderate potential for dependence.
It is not a psychedelic in the classical sense, and it is not an experimental compound. It is a long-established medication being used at a fraction of anesthetic dose for a different purpose.
Why it works differently
Conventional antidepressants act on serotonin and typically take weeks. Ketamine acts on the glutamate system, the brain's most abundant neurotransmitter, and can produce relief within roughly forty minutes to a few hours.
It also appears to promote neuroplasticity, opening a window in which the brain forms new connections more readily. That window is the reason ketamine is paired with psychotherapy rather than given alone. The medication opens the door; the therapy is what walks through it.
How risk is actually managed
In a properly run program, safety is a process rather than a promise.
Screening. A medical and psychological assessment comes first. Blood pressure and cardiac history matter, because ketamine transiently raises both heart rate and blood pressure. A history of psychosis, uncontrolled hypertension, or certain other conditions may rule the treatment out. Screening is where most risk is removed, and a program that skips it is telling you something.
Preparation. Before any medicine session, you should know what the experience will feel like, what the plan is, and what you are working towards. Surprise is the enemy of a good session.
Administration and monitoring. Sessions are conducted under the supervision of qualified medical professionals with vital signs monitored throughout. Route matters: intramuscular injection has a faster onset and often a more profound experience, while sublingual lozenges come on more gently and gradually.
Support during the session. A clinician stays with you. This is the difference between ketamine-assisted psychotherapy and an infusion clinic where you sit in a chair with headphones.
Integration. Afterwards, you process what came up with your therapist. Insight that is never integrated tends to fade.
What the experience is like
During a session you may notice altered perceptions, changes in thought patterns, emotional release, or sudden insight. These are normal features of the experience, not complications, and they typically resolve completely within a few hours after the session. A trained clinical team guides you through them and helps you use them therapeutically.
Transient nausea, dizziness, and a floating or dissociated feeling are common during administration. They pass.
The honest limits
Ketamine is not right for everyone, and no serious provider should suggest otherwise. It is not a cure, it is not permanent on its own, and it works best as part of a structured therapeutic program rather than as a standalone intervention. Response rates in treatment-resistant cases are good but not universal.
It is also not appropriate for someone in acute crisis.
How we do it
At the KAIR Program, ketamine is embedded in a therapeutic framework rather than delivered on its own. Sessions are timed within a three to five day intensive, each one bookended by preparation and integration with the same clinician who is with you all week.
Safety is our highest priority. All ketamine sessions are conducted under the supervision of qualified medical professionals, with vital signs monitored throughout to ensure client safety.
The KAIR Program is designed for deep therapeutic work and is not appropriate for acute crisis situations. If you are in crisis, please contact your local emergency services or crisis hotline for immediate support.
